Elizabeth Holmes

American biotechnology entrepreneur convicted of fraud

Elizabeth Anne Holmes (born February 3, 1984) is an American businesswoman convicted of fraud in connection with her health technology company Theranos. Holmes founded Theranos in 2003, and its valuation soared in the early 2010s after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a fingerprick.

Nº Q17503525 ★★★★★

Ultra Rare · People

Elizabeth Holmes

American biotechnology entrepreneur convicted of fraud

Elizabeth Anne Holmes (born February 3, 1984) is an American businesswoman convicted of fraud in connection with her health technology company Theranos. Holmes founded Theranos in 2003, and its valuation soared in the early 2010s after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a fingerprick.

Last price

—

Floor price

—

7-day median

—

30-day sales

0

30-day range

—

In circulation

0

Price history

Show table
Datemedian LowHighsales

Sales history

Last sale
—
30-day average
—
30-day low
—
30-day high
—
Sales 7d
0
Sales 30d
0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

№ Numbered editions · 0 minted Next #1 · Score ×3
From Wikipedia

Elizabeth Anne Holmes (born February 3, 1984) is an American businesswoman convicted of fraud in connection with her health technology company Theranos. Holmes founded Theranos in 2003, and its valuation soared in the early 2010s after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a fingerprick. In 2015, Forbes had named Holmes the youngest and wealthiest self-made female billionaire in the United States on the basis of a $9-billion valuation of her company. In the following year, as accusations of fraud about Theranos's claims began to surface, Forbes revised its estimate of Holmes's net worth to zero, and Fortune named her in its feature article on "The World's 19 Most Disappointing Leaders". The decline of Theranos began in 2015, when a series of journalistic and regulatory investigations revealed doubts about the company's claims and whether Holmes had been truthful with investors and the government. In 2018, the U.S. Securities and Exchange Commission (SEC) charged Theranos, Holmes, and former Theranos chief operating officer (COO) Ramesh "Sunny" Balwani with raising $700 million from investors through a fraud involving false or exaggerated claims about the accuracy of the company's blood-testing technology; Holmes settled the charges by paying a $500,000 no admit no deny (NAND) fine, returning 18.9 million shares to the company, relinquishing her voting control of Theranos, and accepting a ten-year ban from serving as an officer or director of a public company. Holmes was in a clandestine romantic relationship with Balwani throughout most of Theranos's history. Holmes and Balwani jointly ran the company with a "dysfunctional corporate culture" of "secrecy and fear" according to employees. Staff also claimed that those who "raised concerns or objections" were "usually marginalized or fired" by the pair. Following the collapse of Theranos,...

Text: Wikipédia, CC BY-SA 4.0. · Image: Photo by Max Morse for TechCrunch TechCrunch (CC BY 2.0) ·

Related cards

View card

Confirmation